New technologies for catheter ablation of atrial fibrillation

Current Treatment Options in Cardiovascular Medicine

Volumn 13, Issue 5, 2011, Pages 393-401

  Gerstenfeld, Edward P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ARTICLE; BALLOON CATHETER; CARDIOVASCULAR EQUIPMENT; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CRYOABLATION; ESOPHAGUS FISTULA; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART TAMPONADE; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; LUNG VEIN OBSTRUCTION; PATIENT SAFETY; STROKE; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

EID: 80755146099     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-011-0141-x     Document Type: Article

References (10)

1. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-66. (Pubitemid 28402090)
2. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm. 2011;8(1):157-76. These are the current ACC/AHA guidelines for managing AF.
3. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 2010;303:333-40. The thermocool AF trial compared irrigated AF ablation to antiarrhythmic therapy in a prospective randomized trial and found an overwhelming outcome in favor of ablation. This trial led to approval of the thermocool catheter for AF ablation by the US Food and Drug Administration.
4. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi Jr F, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354(9):934-41.
5. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293:2634-40. (Pubitemid 40744248)
6. Packer DL, Lee KL, Mark DB, Monahan KH, Hoffmann KL, Hafley GE, et al. Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation - Pilot Trial. J Amer Coll Cardiol 2010; Abstract. The CABANA pilot trial compared catheter ablation and medical management of AF in a small, prospective randomized trial. The larger randomized trial is now underway.
7. Packer D, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front Stop-AF trial. J Amer Coll Cardiol. 2010; Abstract 3015-6. The Stop-AF trial compared cryoballoon ablation to antiarrhythmic therapy for treating AF.
8. Reddy VY, Neuzil P, Themistoclakis S, Danik SB, Bonso A, Rossillo A, et al. Visually-guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome. Circulation. 2009;120(1):12-20.
9. Reddy VY, Neuzil P, D'Avila A, Laragy M, Malchano ZJ, Kralovec S, et al. Balloon catheter ablation to treat paroxysmal atrial fibrillation: what is the level of pulmonary venous isolation? Hear Rhythm. 2008;5(3):353-60.
10. Scharf C, Boersma L, Davies W, Kanagaratnam P, Peters NS, Paul V, et al. Ablation of persistent atrial fibrillation using multielectrode catheters and dutycycled radiofrequency energy. J Am Coll Cardiol. 2009;54(15):1450-6.